arrow
F

Friederike Bärhold

University Hospital Tübingen
H指数:5
被引数:69

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Natural Diversity of Grass Pollen in Europe—An EAACI Perspective

欧洲草花粉的自然多样性—<scp>EAACI</scp>观点

2026-10-080
PREAI
Achieving Remission in Chronic Rhinosinusitis With Nasal Polyps Depends on Practical Utilization of Current Criteria and Does not Reflect Therapy Response: Results From a Multi-National Cohort

在鼻息肉慢性鼻窦炎中实现<i>缓解</i>依赖于对当前标准的实际应用,并不反映疗法<i>应答</i>:多国队列研究的结果

2026-10-050
OAAI
The EAACI Declaration of Salamanca: A European Roadmap for Strengthening Undergraduate Medical Education in Allergy and Clinical Immunology

EAACI萨拉曼卡宣言:加强变态反应学和临床免疫学本科医学教育的欧洲路线图

2026-09-240
OAAI
The First Biosimilar for Biologics in Allergy: CT-P39 (Omlyclo-Omalizumab-Igec) Is Available for Asthma, Chronic Spontaneous Utricaria, and Chronic Rhinosinusitis With Nasal Polyps

首个用于过敏领域的生物类似药:CT-P39(Omlyclo-Omalizumab-Igec)适用于哮喘、慢性自发性荨麻疹和伴有鼻息肉的慢性鼻窦炎

2026-04-250
PRE
Photon-Counting Computed Tomography of the Paranasal Sinuses Improves Intraoperative Accuracy of Image-Guided Surgery

鼻窦光子计数计算机断层扫描提高了图像引导手术的术中准确性

2026-03-030
OAAI
Correspondence: First Peanut (Arachis hypogaea) Allergen Oral Immunotherapy Product Out of Sale—A Major Drawback for Food Allergy Immunotherapy?

通讯:首个花生(Arachis hypogaea)过敏原口服免疫疗法产品退出销售——这对食物过敏免疫疗法是一个重大挫折?

2026-02-120
PRE
The Unmet Need of Olfactory Testing in Inflammatory Disorders of the Upper Airways—An EAACI Position Paper

上气道炎症性疾病中嗅觉测试的未满足需求——EAACI立场文件

2026-02-020
PRE
Feasibility of Dose Reduction in the Context of Preoperative Diagnostics in Cochlear Implant Surgery With a Photon-Counting Detector CT and Deep Learning-Supported Denoising

在光子计数探测器CT和深度学习支持的降噪技术辅助下,人工耳蜗手术术前诊断中剂量减少的可行性研究

2026-01-010
PRE
Otitis Media With Effusion (OME) and Eustachian Tube Dysfunction: The Role of Allergy and Immunity-An EAACI Position Paper

分泌性中耳炎(OME)与咽鼓管功能障碍:过敏与免疫的作用——EAACI立场文件

2025-04-170
PREAI
Hepatorenal Tyrosinaemia: Impact of a Simplified Diet on Metabolic Control and Clinical Outcome
2020-12-318
OAAI